Follow-The-Filings

Security · featured owners

DOCS Doximity Inc.

Health Care CL A Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.1%
  • $14M
  • 1 reduce

DOCS (Doximity Inc.) is held in 1 featured 13F book as of 2026 Q2. Terry Smith - Fundsmith is the largest tracked holder by portfolio weight (0.10%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.1% (Terry Smith - Fundsmith) · not free-float ownership

  1. Terry Smith reduce 0.10%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Terry Smith - Fundsmith 2026 Q2 0.10% Reduce −5.6% 653,324 $14M history

1 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 9 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
10-K Filing Doc
8-K 2.02,5.02,9.01 Filing Doc
8-K 5.02,7.01 Filing Doc
8-K 2.02,5.02,9.01 Filing Doc
10-Q Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 17 rows shown

Filed Form Detail Links
4 Period Sep 15, 2026 Filing Doc
4 Period Sep 1, 2026 Filing Doc
4 Period Aug 27, 2026 · 5 forms Filing Doc
4 Period Aug 25, 2026 Filing Doc
4 Period Aug 15, 2026 · 3 forms Filing Doc
4 Period Aug 13, 2026 Filing Doc
4 Period Aug 7, 2026 Filing Doc
4 Period Jul 22, 2026 · 2 forms Filing Doc
4 Period Jul 15, 2026 Filing Doc
4 Period Jul 13, 2026 Filing Doc
4/A Period Nov 15, 2025 Filing Doc
4 Period May 15, 2026 Filing Doc
4 Period Jun 8, 2026 Filing Doc
4 Period May 15, 2026 · 2 forms Filing Doc
4 Period May 11, 2026 Filing Doc
4 Period May 7, 2026 Filing Doc
4 Period Apr 10, 2026 Filing Doc

Updated about 16 hours ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025 FY2026
Revenue $419.05M $475.42M $570.4M $644.86M
Gross profit $365.56M $424.75M $514.52M $574.54M
Gross margin * 87.2% 89.3% 90.2% 89.1%
Net income $112.82M $147.58M $223.18M $196.05M
Net margin * 26.9% 31.0% 39.1% 30.4%

Balance sheet

Metric FY2023 FY2024 FY2025 FY2026
Total current assets $0.975B $0.913B $1.09B $0.944B
Total non-current assets * $161.44M $166.43M $175.69M $179.42M
Total assets $1.14B $1.08B $1.26B $1.12B
Total current liabilities $139.51M $147.25M $156.26M $154.97M
Total non-current liabilities * $31.26M $30.73M $25.43M $17.88M
Total equity $0.966B $0.901B $1.08B $0.951B

Cash flow

Metric FY2023 FY2024 FY2025 FY2026
Cash from operations $179.6M $184.1M $273.26M $326.46M
Cash from investing -$59.92M $31.19M -$29.3M $147.17M
Cash from financing -$74.46M -$276.52M -$131.14M -$464.06M
Net change in cash $45.22M -$61.24M $112.83M $9.56M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders